The investment is through the state’s Maryland Department of Business and Economic Development InvestMaryland program. Cytomedix is working on a $27.5 million capital campaign, and is looking to add 13 employees and increase worldwide marketing, according to the report.
In addition to the AutologGel System, Cytomedix produces the Angel Whole Blood Separation System for orthopedic and surgical uses.
More Articles on Devices:
OrthoData Receives $250k Investment for Developing Spine Technologies
Stryker Unveiled Iconix All Suture Device for Shoulder, Hip Arthroscopy
Biomaterials Market Estimated at $88.4B by 2017
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
